AI Ophthalmology and Optometry | Altris AI

AI for Geographic Atrophy

Book free trial to see how AI can detect GA and 70+ other pathologies/biomarkers

Book Intro AI Ophthalmology and Optometry | Altris AI

Altris AI is an AI Decision Support for OCT Analysis that leverages objective AI for Geographic Atrophy (GA) detection and comprehensive progression monitoring.

Detection of GA biomarkers: Hypertransmission, RPE atrophy, Neurosensory retina atrophy, EZ disruption, RPE disruption.

Objective measurement of each GA biomarker as well as GA lesions.

Precise calculation of GA lesions based on the overlap of two biomarker sets: Hypertransmission + RPE Atrophy and Hypertransmission + RPE Atrophy + Neurosensory Retina Atrophy.

Additional parameters: detection of the foveal zone and calculation of the distance from the fovea to the GA area, as well as the coverage of the macula by GA lesions.

Progression tracking of each biomarker and GA lesions in mm and percentages.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA-cleared (510k).

Alisdair Buchanan Clinical Director

As someone already confident in interpreting scans, I didn’t need help understanding OCT—but Altris AI provides something even more valuable: a kind of second opinion. It supports my clinical decisions and offers an added layer of reassurance, particularly in borderline or complex cases. That’s not just helpful—it’s powerful.

7 May, 2025

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Quickly and accurately track how Geographic Atrophy is changing with the dedicated GA Progression feature, which compares patient data from multiple visits. Explore changes in the entire GA area and individual biomarkers through intuitive visualizations presented as percentages, maps, and graphs. Leverage these error-free, reproducible measurements to determine the optimal treatment course.

Speeded-up workflow with immediate automated GA area calculations.
Objective GA and biomarker measurements for precise trial actions.
Confident decision-making based on distance GA from the fovea and GA macular coverage measurements.
Enhanced patient stratification based on the most accurate 3-biomarker overlap GA area calculation.

Analyze the overlap of GA biomarkers.

Determine GA area precisely.

See GA-fovea distance and macular coverage.

Track pathological changes over time.

How Altris AI works?

And what's the value of using Artificial intelligence for Geographic Atrophy

Altris AI is a web platform created by retina experts for all eye care specialists and clinicians.

We’ve collected millions of OCT scans, and our team graphically labeled thousands of them to create the Altris AI system that can:

Detect over 70 pathologies and biomarkers, including 4 fluid types.

Measure and track pathological changes across multiple examinations.

Monitor the progression of fluid for better patient outcomes.

Get clinical insights with the help of objective measurements.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Clinical Research

What you get with Altris AI:

Accelerate ophthalmic drug trial with AI
Detect GA and its biomarkers ( as well as 70+ retinal pathologies and biomarkers)
Track the progression of biomarkers to assess drug efficiency
Enroll the right patients based on fast biomarkers detection
Reduce costs associated with manual scan review with automated analysis
Reduce human made errors to the minimum

For Eye Care

We support you through the whole way

14 Days of Free Trial to see the value
Support during the whole trial period
Early glaucoma assessment module access
CE-certified, GDPR, HIPAA compliant, FDA clearance
Integration support with any EHR, EMR system.
Access to the whole functional during trial

Contact us

Ask us any question

For a clinic or an optometry: we will show the system to you during 15-minute call and then you will have a free trial to test it yourself.

Book intro + free trial

Any eye care practitioner can test it for a personal use for free

Demo